Avita Medical | Fremdkapital



Loan Capital Veränderung Datum
Adcock Ingram Holdings ZAR 238.08M 21.45M 2024-06
Celltrion KRW 79.58B 21.94B 2024-09
Clinuvel Pharmaceuticals AUD 509.92K 203.14K 2024-06
Cochlear AUD 202.1M 35.2M 2024-06
CSL USD 11.24B 552M 2024-06
Cspc Pharmaceutical CNY 56.14M 10.18M 2024-12
Dianthus Therapeutics USD 0 0 2024-12
Ecofibre AUD 9.5M 0 2024-06
Kangmei Pharma CNY 169.19M 7.26M 2024-09
Knight Therapeutics CAD 36.51M 2.04M 2024-09
Laboratorios Farma EUR 80.5M 17.64M 2024-12
Malin Corporation EUR 0 0 2024-06
Mayne Pharma AUD 31.64M 1.47M 2024-06
Medical Developments International AUD 1.91M 146K 2024-06
Nanosonics AUD 6.16M 1.47M 2024-06
Neuren Pharmaceuticals AUD 0 0 2024-12
Organigram Holdings CAD 43.29M 12.19M 2024-12
Pacific Edge NZD 1.77M 744K 2024-09
Paradigm Biopharmaceuticals AUD 20.57K 156.46K 2024-06
Pharma Mar EUR 41.23M 999K 2024-12
Polynovo AUD 12.84M 857K 2024-06
PYC Therapeutics AUD 803K 583.2K 2024-06
Qiagen NV USD 1.34B 26.51M 2024-12
Ramsay Health Care AUD 10.69B 359.3M 2024-12
ResMed USD 662.86M 4.72M 2024-12
Sartorius EUR 4.43B 106.8M 2024-09
Sino Biopharmaceutical CNY 2.08B 915.47M 2024-12
Telix Pharmaceuticals AUD 551.82M 533.46M 2024-12
Tilray USD 316.63M 15.02M 2024-11
Zz Pientze Pharmaceu 162.42M 4.3M 2024-09



Avita Medical Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.